Tuesday, 18 August, 2020
CEPI (the Coalition for Epidemic Preparedness Innovations), Gavi and the World Health Organisation (WHO) are seeking representatives from civil society and community organisations (CSOs) to participate in COVAX - the vaccines pillar of the Access to COVID-19 Tools Accelerator - which aims to develop, manufacture and fairly allocate 2 billion doses of safe and effective COVID-19 vaccine by the end of 2021 to end the acute phase of the COVID-19 pandemic.
CSOs will play a role in the development and implementation of the COVAX initiative as well as the deployment of any successful vaccine through COVAX.
Specifically, CEPI are looking for CSO representatives to participate in coordination meetings and a number of specific workstreams of COVAX, in particular:
It is anticipated that the roles of CSOs will include:
CEPI are also looking for representatives’ input in building public trust and capacity across healthcare systems for COVID-19 vaccination programmes.
Nominated representatives should:
The deadline for applications is 25 August 2020.
More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.